Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Parathyroid Glands

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...

Hormones and Bone Tissue

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biochemical evaluation of X-linked hypophosphatemia and tumor-induced osteomalacia: insights into diagnosis and management.

Frontiers in endocrinology·2025

Same author

Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022

Same author

Guide of management of alterations in mineral and bone metabolism during gestation and lactation.

Endocrinologia, diabetes y nutricion·2022

Same author

New technologies in the evaluation of bone fragility and its application in Endocrinology.

Endocrinologia, diabetes y nutricion·2020

Same author

Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia.

Endocrinologia, diabetes y nutricion·2019

Same author

Is vitamin-D supplementation not useful in patients at risk of fractures and falls?

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2019

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

[Consensus and clinical practice guidelines in primary hyperparathyroidism].

Esteban Jódar Gimeno¹

¹Servicio de Endocrinología y Nutrición, Hospital Quirón, Madrid, España. esteban.jodar@gmail.com

Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion

|July 25, 2009

Summary

This summary is machine-generated.

Primary hyperparathyroidism (PHPT) diagnosis and treatment have evolved, with many cases now detected incidentally. Guidelines help determine surgery for asymptomatic patients, while medical management and localization techniques aid treatment.

More Related Videos

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jun 21, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Area of Science:

Endocrinology
Metabolic Bone Disease

Context:

Primary hyperparathyroidism (PHPT) presentation and management have significantly evolved due to automated diagnostics.
Increased detection of PHPT during investigations for osteoporosis and kidney stones.
Emerging links between PHPT and cardiovascular/neurocognitive conditions.

Purpose:

To review the updated diagnostic criteria and treatment recommendations for PHPT.
To outline surgical indications for both symptomatic and asymptomatic patients.
To discuss medical management options and the role of localization techniques.

Summary:

Modern diagnostics detect PHPT more frequently, often incidentally, shifting focus from classical bone/renal symptoms.
Surgical intervention is recommended for symptomatic PHPT; guidelines now specify criteria for operating on asymptomatic individuals.
Medical management involves regular monitoring and potential pharmacotherapy (bisphosphonates, raloxifene, cinacalcet).
Parathyroid scintigraphy and intraoperative hormone monitoring assist in surgical planning and reoperations.

Impact:

Refined surgical decision-making for asymptomatic PHPT based on age, biochemical markers, and bone health.
Improved management strategies integrating medical and surgical approaches.
Enhanced surgical outcomes through advanced localization and intraoperative monitoring techniques.